Bojana N. Stamenkovic
Niska Banja, SE, Serbia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133).
Journal: Annals of the rheumatic diseases
Published: February 03, 2025
Interleukin 41 As A Potential Predictor of Bio-Therapy Efficacy In Patients With Rheumatoid Arthritis: A Prospective Observational Study.
Journal: International journal of medical sciences
Published: May 22, 2024
Relationship between socio-descriptive characteristics, burnout syndrome, and quality of life of employees.
Journal: Frontiers in public health
Published: August 14, 2023
Etiology, Predisposing Factors, Clinical Features and Diagnostic Procedure of Otomycosis: A Literature Review.
Journal: Journal of fungi (Basel, Switzerland)
Published: May 12, 2023
Matrix Metalloproteinase-9 Level in Synovial Fluid-Association with Joint Destruction in Early Rheumatoid Arthritis.
Journal: Medicina (Kaunas, Lithuania)
Published: November 07, 2022
Knowledge about HPV Infection and the HPV Vaccine among Parents in Southeastern Serbia.
Journal: Medicina (Kaunas, Lithuania)
Published: September 20, 2022
Is Osteoarthritis Always Associated with Low Bone Mineral Density in Elderly Patients?
Journal: Medicina (Kaunas, Lithuania)
Published: July 21, 2022
Low-Frequency Magnetic Resonance Imaging Identifies Hand Joint Subclinical Inflammation in Systemic Sclerosis.
Journal: Diagnostics (Basel, Switzerland)
Published: July 12, 2022
Structural damage of the hand in hand osteoarthritis: impact on function, pain, and satisfaction.
Journal: Hippokratia
Published: January 01, 2022
Electrocardiographic criteria which have the best prognostic significance in hypertensive patients with echocardiographic hypertrophy of left ventricle: 15-year prospective study.
Journal: Clinical cardiology
Published: April 17, 2020
Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: June 12, 2019
Analysis on the risk factors for organ damage in patients with systemic lupus erythematosus: a cross-sectional single-center experience.
Journal: Sao Paulo medical journal = Revista paulista de medicina
Published: January 01, 2019
Last Updated: 09/26/2026